These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 395674

  • 41. [Biological investigation of thyroid cancer].
    Douik H, Ghanem A, Jmal A, Harzallah L, Gara S, Abdennebi M, Boussen H, Guemira F.
    Tunis Med; 2006 Mar; 84(3):135-41. PubMed ID: 16755952
    [Abstract] [Full Text] [Related]

  • 42. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF, Fritsche HA, Samaan NA.
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [Abstract] [Full Text] [Related]

  • 43. [Problems posed by medullary cancer of the thyroid].
    Calmettes C.
    Rev Med Interne; 1984 Nov; 5(4):279-82. PubMed ID: 6151728
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Familial medullary cancer of the thyroid and familial pheochromocytoma].
    Milhaud G.
    Actual Endocrinol (Paris); 1973 Nov; 13(0):107-16. PubMed ID: 4793597
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Thyroid cancer: tumour markers.
    Stevenson JC, Hillyard CJ.
    Recent Results Cancer Res; 1980 Nov; 73():60-7. PubMed ID: 6785846
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
    Takami H, Ito K.
    Int Surg; 1992 Nov; 77(3):181-5. PubMed ID: 1399365
    [Abstract] [Full Text] [Related]

  • 54. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC, Gross MD, Frietas JE, Jackson CE, England BG.
    Henry Ford Hosp Med J; 1981 Nov; 29(2):75-80. PubMed ID: 7263287
    [No Abstract] [Full Text] [Related]

  • 55. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
    Lloyd RV, Sisson JC, Marangos PJ.
    Cancer; 1983 Jun 15; 51(12):2234-9. PubMed ID: 6342746
    [Abstract] [Full Text] [Related]

  • 56. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
    Gautvik KM.
    Tidsskr Nor Laegeforen; 1973 May 30; 93(15):1143-8. PubMed ID: 4584540
    [No Abstract] [Full Text] [Related]

  • 57. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
    Palmer BV, Harmer CL, Shaw HJ.
    Br J Surg; 1984 Feb 30; 71(2):101-4. PubMed ID: 6692098
    [Abstract] [Full Text] [Related]

  • 58. Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma.
    Calmettes C, Caillou B, Moukhtar MS, Milhaud G, Gerard-Marchant R.
    Cancer; 1982 Jun 01; 49(11):2342-8. PubMed ID: 7042069
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.